Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
The ‘PreventiPlaque’ randomized controlled trial: Psychological influences on the efficacy of a mHealth intervention for cardiovascular risk reduction
ABSTRACT
Background:
Atherosclerotic cardiovascular diseases (ACD) are the leading global cause of disease and mortality. Since secondary prevention targets key modifiable risk factors, addressing mental health is essential, as impaired mental health increases cardiovascular risk and reduces treatment adherence. The personalized mHealth intervention ‘PreventiPlaque’ demonstrated its efficacy in improving cardiovascular and secondary risk factors in patients with ACD.
Objective:
This analysis of the ‘PreventiPlaque’ randomized controlled trial (RCT) investigates psychological factors influencing the app’s efficacy in cardiovascular risk reduction and the intervention’s effects on psychological well-being.
Methods:
This analysis of the two-arm ‘PreventiPlaque’ RCT (intervention vs. treatment as usual) included N = 240 patients with ACD (intervention group: n = 119, controls: n = 121). Psychological factors included depression, anxiety symptoms, distress, subjective physical well-being, and sense of positive and negative agency. Cardiovascular risk profile was assessed according to Systematic Coronary Risk Evaluation (SCORE2). Statistical analysis utilized linear mixed effects models and repeated measure ANOVAs (within-between).
Results:
Linear mixed effects models revealed no relevant psychological moderators of the intervention’s effect on the cardiovascular risk profile (p > .05). The intervention did not significantly improve psychological outcomes (p > .05), except for a stabilization of subjective physical well-being in the intervention group (p = .027).
Conclusions:
‘PreventiPlaque’s efficacy was largely independent of psychological factors, suggesting the mHealth intervention is robust and accessible even for more patients affected by mental health issues. The app successfully stabilized subjective physical well-being which declined in the control group over time. Clinical Trial: The study was registered at ClinicalTrials.gov under the identifier NCT05096637 on 27 October 2021.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.